Cerevance is a private pharmaceutical company focused on central nervous system diseases. Its proprietary NETSseq technology enables the company to produce comprehensive transcriptional profiles of specific brain cell types from mature human brain tissue.
In this on-demand webinar, Dr. Steven Sheardown describes the rationale for this approach, how the NETSseq method works, and how Cerevance has used the Trio RNA-Seq Library Preparation Kit to generate data from difficult materials. To date, the company has produced over 5,000 high quality, cell type-specific datasets from control and disease tissues, and it is positioned to deliver life-changing therapeutics for patients who have brain-related disorders.
Offered Free by: Tecan
See All Resources from: Tecan